Stock Price, News, Quote and Profile of MIRA PHARMACEUTICALS INC(NASDAQ:MIRA) stock

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

MIRA PHARMACEUTICALS INC

NASDAQ:MIRA (5/9/2024, 3:23:16 PM)

After market: 0.7424 -0.01 (-1.01%)

0.75

-0.01 (-1.3%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryPharmaceuticals

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Overview

Earnings (Last)

Earnings (Next)

Ins Owners

Inst Owners

Market Cap11.09M

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts

IPO

Stock Screener Links

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Mira Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Baltimore, Maryland and currently employs 1 full-time employees. The company went IPO on 2023-08-03. MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company. The firm is focused on the development and commercialization of molecular synthetic cannabinoid analog for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. The firm is developing its product candidate, MIRA1a, for the treatment of neuropsychiatric, inflammatory and neurologic diseases and disorders. MIRA1a is a synthetic cannabinoid analog for treating anxiety and chronic pain by striking a balance between the beneficial effects of tetrahydrocannabinol (THC) and cannabidiol (CBD) by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors.

Company Info

MIRA PHARMACEUTICALS INC

855 N Wolfe Street #623-6

Baltimore MARYLAND

P: 18133695150

Employees: 1

Website: https://mirapharmaceuticals.com/

MIRA News

a month ago - InvestorPlaceMIRA Stock Earnings: Mira Pharmaceuticals Beats EPS for Q4 2023

MIRA stock results show that Mira Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.

a month ago - BusinessInsiderMIRA Stock Earnings: Mira Pharmaceuticals Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mira Pharmaceuticals (NASDAQ:MIRA) just reported results for the fourth quarter...

a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time to dive into the biggest pre-market stock movers for Wednesday morning as we check out all of the hottest news!

2 months ago - MIRA Pharmaceuticals, Inc.MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor

/PRNewswire/ -- MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), an innovative pre-clinical-stage pharmaceutical company focused on the...